Risk Factors for Low Quality of Life among Women Using Different Types of Contraceptives in Saudi Arabia: A Questionnaire-Based Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Sample Size and Sampling Technique
2.2. Inclusion Criteria and Exclusion Criteria
2.3. Data Collection Instrument and Process
2.4. Statistical Analysis
3. Results
3.1. Demographic Characteristics
3.2. Menstruation Characteristics
3.3. Factor Analysis
3.4. Reliability
3.5. Risk Factors for Higher Overall Spanish Society of Contraception Quality of Life Scores
3.6. Risk Factors for Higher Physiological Symptom Scores
3.7. Risk Factors for Higher Sexual Symptom Scores
3.8. Risk Factors for Higher Psychological Symptoms Scores
3.9. Risk Factors for Higher Breast Symptom Scores
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Teal, S.; Edelman, A. Contraception selection, effectiveness, and adverse effects: A review. JAMA 2021, 326, 2507–2518. [Google Scholar] [CrossRef] [PubMed]
- Saudi Arabia General Authority for Statistics. Household Health Survey 2018. Available online: https://www.stats.gov.sa/en/news/326 (accessed on 6 April 2024).
- Mahfouz, M.S.; Elmahdy, M.; Ryani, M.A.; Abdelmola, A.O.; Kariri, S.A.; Alhazmi, H.Y.; Almalki, S.H.; Adhabi, O.M.; Ali Hindi, S.M.; Muqri, N.M.; et al. Contraceptive use and the associated factors among women of reproductive age in Jazan City, Saudi Arabia: A cross-sectional survey. Int. J. Environ. Res. Public Health 2023, 20, 843. [Google Scholar] [CrossRef] [PubMed]
- Shamrani, H.M.; Shamrani, A.F.; Alsaggaf, A.E.; Khojah, M.I.; Alafif, M.M.; Tayeb, S.O.; Qari, Y.A.; Harakeh, S.M. Knowledge, attitude and practice of women in Jeddah towards the use of oral contraceptive pills. Saudi J. Intern. Med. 2017, 7, 5–10. [Google Scholar] [CrossRef]
- Alsaleem, M.A.; Khalil, S.N.; Siddiqui, A.F.; Alzahrani, M.M.; Alsaleem, S.A. Contraceptive use as limiters and spacers among women of reproductive age in southwestern, Saudi Arabia. Saudi Med. J. 2018, 39, 1109. [Google Scholar] [CrossRef] [PubMed]
- Alhusain, F.; Alkaabba, F.; Alhassan, N.; Alotaibi, S.; Breakeit, S.; Musaudi, E.; Alhasan, A. Patterns and knowledge of contra-ceptive methods use among women living in Jeddah, Saudi Arabia. Saudi J. Health Sci. 2018, 7, 121–126. [Google Scholar] [CrossRef]
- Gill, T.M.; Feinstein, A.R. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994, 272, 619–626. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Campos, E.; Dueñas, J.L.; de la Viuda, E.; Gómez, M.Á.; Lertxundi, R.; Sánchez-Borrego, R.; Canals, I.; Bermejo, R.; Arbat, A.; Badia, X.; et al. Development and vali-dation of the SEC-QoL questionnaire in women using contraceptive methods. Value Health 2011, 14, 892–899. [Google Scholar] [CrossRef] [PubMed]
- Cristobal, I.; Lete, L.I.; De la Viuda, E.; Perulero, N.; Arbat, A.; Canals, I. One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users. Contraception 2016, 93, 367–371. [Google Scholar] [CrossRef] [PubMed]
- Leon-Larios, F.; Vazquez-Valeo, C.G.; Sanchez-Sanchez, A.; Gomez-Baya, D.; Macías-Seda, J.; Cabezas-Palacios, M.N. Health-related quality of life in undergraduate women using any contraceptive. Health Qual. Life Outcomes 2019, 17, 90. [Google Scholar] [CrossRef] [PubMed]
- Gharaibeh, M.K.; Alsharm, S.; Al Maaitah, R.; Heilat, H.B.; Marayan, L. Quality of life and health status of Jordanian women users of various contraceptive methods and associated factors: Implications for contraceptive policies. Patient Prefer. Adherence 2022, 16, 403–412. [Google Scholar] [CrossRef] [PubMed]
- KSA. Vision 2030. Riyadh Ministry of Planning and Economic Development; 2016. Update 2016. Available online: https://www.vision2030.gov.sa/media/rc0b5oy1/saudi_vision203.pdf (accessed on 20 May 2024).
- Alharthi, H.F.; Alotaibi, M.; Kofi, M. Impact of Intrauterine Device and Oral Contraceptive Pills on the Quality of Life of Women in Saudi Arabia. J. Fam. Med. Prim. Care Open Access 2023, 7, 213. [Google Scholar]
- Farrokh-Eslamlou, H.; Oshnouei, S.; Heshmatian, B.; Akbari, E. Premenstrual syndrome and quality of life in Iranian medical students. Sex Reprod. Health 2015, 6, 23–27. [Google Scholar] [CrossRef]
- Lustyk, M.K.; Widman, L.; Paschane, A.; Ecker, E. Stress, quality of life and physical activity in women with varying degrees of premenstrual symptomatology. Women Health 2004, 39, 35–44. [Google Scholar] [CrossRef] [PubMed]
- Harada, T.; Momoeda, M.; Taketani, Y.; Hoshiai, H.; Terakawa, N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: A placebo-controlled, double-blind, randomized trial. Fertil. Steril. 2008, 90, 1583–1588. [Google Scholar] [CrossRef] [PubMed]
- Higgins, J.A.; Smith, N.K. The sexual acceptability of contraception: Reviewing the literature and building a new concept. J. Sex Res. 2016, 53, 417–456. [Google Scholar] [CrossRef] [PubMed]
- Cetin, A. Evaluation of biological and sociodemographic factors affecting dysmenorrhea. Cureus 2020, 12, e7977. [Google Scholar] [CrossRef] [PubMed]
- Al-Shahrani, H.F.; Hammad, M.A. Relationship between emotional divorce and alexithymia among married women in Saudi Arabia. BMC Psychol. 2023, 11, 217. [Google Scholar] [CrossRef] [PubMed]
- Alhammadi, M.H.; Albogmi, A.M.; Alzahrani, M.K.; Shalabi, B.H.; Fatta, F.A.; AlBasri, S.F. Menstrual cycle irregularity during examination among female medical students at King Abdulaziz University, Jeddah, Saudi Arabia. BMC Women’s Health 2022, 22, 367. [Google Scholar] [CrossRef] [PubMed]
- Alaskar, B.; Alhunaif, S.; Shaheen, M.A.; Alkadri, H. Menstrual abnormalities and their association with stress and quality of life among females studying health sciences. Res. Sq. 2021, 54, 72–77. [Google Scholar]
- Tahir, M.T.; Shamsudeen, S. Mastalgia; StatPearls Publishing: Treasue Island, FL, USA, 2022. Available online: https://www.ncbi.nlm.nih.gov/books/NBK562195/ (accessed on 20 April 2024).
- Henkel, A.; Reeves, M.F.; Shaw, K.A. The experience of breast symptoms after second-trimester abortion or loss. Contraception 2023, 121, 110017. [Google Scholar] [CrossRef]
Characteristic | N (%) |
---|---|
Age (years) | |
<20 | 8 (1.2%) |
21–30 | 237 (36.3%) |
31–40 | 290 (44.5%) |
41–50 | 104 (16.0%) |
>50 | 13 (2.0%) |
Education | |
General education | 90 (13.8%) |
Diploma/bachelor’s degree | 492 (75.5%) |
Postgraduate | 70 (10.7%) |
Monthly income (SAR) | |
<5000 | 263 (40.3%) |
5000–10,000 | 167 (25.6%) |
>10,000–20,000 | 153 (23.5%) |
>20,000–30,000 | 41 (6.3%) |
>30,000 | 28 (4.3%) |
Currently working | |
Yes | 296 (45.4%) |
No | 356 (54.6%) |
Living with husband | |
Yes | 591 (90.6%) |
No | 61(9.4%) |
Relationship with husband | |
Good | 327 (50.2%) |
Somewhat good | 272 (41.7%) |
Not good | 53 (8.1%) |
Number of children | 3.0 (1.0–4.0) |
Number of abortions * | |
None | 431 (68.8%) |
1–2 | 129 (20.6%) |
3–4 | 66 (10.5%) |
Stillbirths | |
Yes | 88 (13.5%) |
No | 564 (86.5%) |
Contraception used | |
Pills | 336 (51.5%) |
Male condom | 95 (14.6%) |
Female condom | 3 (0.5%) |
Hormonal IUD | 32 (4.9%) |
Copper IUD | 73 (11.2%) |
Periodic abstinence | 61 (9.4%) |
Implants | 38 (5.8%) |
Injections | 9 (1.4%) |
Lactation amenorrhea method | 5 (0.8%) |
Blood flow during menstruation | |
Very little | 26 (4.0%) |
Little | 80 (12.3%) |
Normal | 492 (75.5%) |
Severe bleeding | 54 (8.3%) |
Type of pad | |
Light flow | 145 (22.2%) |
Regular flow | 414 (63.5%) |
Heavy flow | 93 (14.3%) |
Blood clots | |
Yes | 351 (53.8%) |
No | 301 (46.2%) |
Regular menstruation | |
Yes | 462 (80.2%) |
No | 190 (19.8%) |
Breast-related premenstrual symptoms | |
Pain | 344 (52.8%) |
Hypersensitivity | 338 (51.8%) |
Increased size | 259 (39.7%) |
Variable | Factor 1 | Factor 2 | Factor 3 | Factor 4 | Factor 5 |
---|---|---|---|---|---|
Ph_1 | 0.159 | 0.623 | 0.101 | 0.160 | 0.112 |
Ph_2 | 0.192 | 0.578 | 0.063 | 0.149 | 0.100 |
Ph_3 | 0.145 | 0.671 | 0.127 | 0.082 | 0.021 |
Sex_3 | 0.177 | −0.003 | 0.126 | 0.000 | 0.564 |
Sex_4 | 0.068 | 0.163 | 0.052 | 0.087 | 0.527 |
Psy_3 | 0.246 | 0.160 | 0.868 | 0.073 | 0.147 |
Psy_5 | 0.330 | 0.171 | 0.809 | 0.102 | 0.145 |
Soc_1 | 0.717 | 0.363 | 0.215 | 0.084 | 0.152 |
Soc_2 | 0.674 | 0.406 | 0.204 | 0.140 | 0.149 |
Soc_3 | 0.506 | 0.026 | 0.139 | 0.025 | 0.073 |
Soc_4 | 0.628 | 0.199 | 0.149 | 0.162 | 0.155 |
Br_1 | 0.128 | 0.417 | 0.097 | 0.501 | 0.134 |
Br_2 | 0.149 | 0.210 | 0.084 | 0.960 | 0.042 |
Characteristic | Beta Coefficient | 95% CI | p-Values |
---|---|---|---|
Risk factors for higher overall SEC-QOL scores | |||
Relationship with husband | |||
Good | Reference | Reference | |
Somewhat good | 0.18 | 0.09, 0.27 | <0.001 * |
Not good | 0.44 | 0.27, 0.62 | <0.001 * |
Type of pad | |||
Light flow | Reference | Reference | |
Regular flow | 0.08 | −0.03, 0.18 | 0.147 |
Heavy flow | 0.30 | 0.15, 0.45 | <0.001 * |
Premenstrual breast symptoms | |||
Pain | |||
No | Reference | Reference | |
Yes | 0.33 | 0.24, 0.42 | <0.001 * |
Hypersensitivity | |||
No | Reference | Reference | |
Yes | 0.10 | 0.01, 0.19 | 0.029 * |
Increased size | |||
No | Reference | Reference | |
Yes | 0.21 | 0.12, 0.30 | <0.001 * |
Regular menstruation | |||
No | Reference | Reference | |
Yes | −0.11 | −0.22, 0.00 | 0.043 * |
Physiological Domain | |||
Relationship with husband | |||
Good | Reference | Reference | |
Somewhat good | 0.19 | 0.06, 0.31 | 0.005 * |
Not good | 0.08 | −0.17, 0.33 | 0.507 |
Contraception used | |||
Pills | Reference | Reference | |
Male condoms | 0.11 | −0.08, 0.29 | 0.253 |
Female condoms | −1.04 | −2.47, 0.40 | 0.158 |
Hormonal IUDs | 0.32 | 0.02, 0.63 | 0.040 * |
Copper IUDs | 0.19 | −0.01, 0.40 | 0.065 |
Periodic abstinences | 0.29 | 0.07, 0.50 | 0.009 * |
Implants | 0.04 | −0.22, 0.31 | 0.738 |
Injections | 0.79 | 0.30, 1.28 | 0.002 * |
Lactation amenorrhea method | −0.10 | −0.92, 0.73 | 0.819 |
Type of pad | |||
Light flow | Reference | Reference | |
Regular flow | 0.17 | 0.02, 0.32 | 0.026 * |
Heavy flow | 0.40 | 0.19, 0.62 | <0.001 * |
Sexual Domain | |||
Relationship with husband | |||
Good | Reference | Reference | |
Somewhat good | 0.25 | 0.12, 0.39 | <0.001 * |
Not good | 0.52 | 0.26, 0.78 | <0.001 * |
Contraception used | |||
Pills | Reference | Reference | |
Male condom | −0.19 | −0.38, −0.01 | 0.044 * |
Female condom | −0.06 | −1.54, 1.43 | 0.941 |
Hormonal IUD | −0.01 | −0.33, 0.32 | 0.966 |
Copper IUD | 0.33 | 0.11, 0.54 | 0.003 * |
Periodic abstinence | −0.16 | −0.38, 0.06 | 0.162 |
Implants | 0.11 | −0.18, 0.40 | 0.461 |
Injections | 0.54 | 0.03, 1.05 | 0.040 * |
Lactation amenorrhea method | 0.55 | −0.31, 1.41 | 0.214 |
Pain | |||
No | Reference | Reference | |
Yes | 0.16 | 0.04, 0.29 | 0.013 * |
Psychological Domain | |||
Relationship with husband | |||
Good | Reference | Reference | |
Somewhat good | 0.26 | 0.10, 0.42 | 0.001 * |
Not good | 0.78 | 0.47, 1.10 | <0.001 * |
Menstruation amount | |||
Light amount | Reference | Reference | |
Regular amount | 0.10 | −0.11, 0.32 | 0.351 |
Heavy amount | 0.39 | 0.06, 0.72 | 0.020 * |
Breast Domain | |||
Currently working | |||
No | Reference | Reference | |
Yes | 0.19 | 0.05, 0.32 | 0.007 * |
Number of abortions | |||
None | Reference | Reference | |
1 to 2 | −0.18 | −0.35, −0.02 | 0.031 * |
3 to 4 | 0.03 | −0.19, 0.26 | 0.790 |
Type of pad | |||
Light flow | Reference | Reference | |
Regular flow | 0.10 | −0.06, 0.26 | 0.225 |
Heavy flow | 0.37 | 0.14, 0.60 | 0.002 * |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alhakeem, M.M.; Baghdadi, L.R.; Alshathri, A.H.; Alshathri, A.H.; Alqahtani, A.A.; Alshathri, M.H. Risk Factors for Low Quality of Life among Women Using Different Types of Contraceptives in Saudi Arabia: A Questionnaire-Based Study. Behav. Sci. 2024, 14, 829. https://doi.org/10.3390/bs14090829
Alhakeem MM, Baghdadi LR, Alshathri AH, Alshathri AH, Alqahtani AA, Alshathri MH. Risk Factors for Low Quality of Life among Women Using Different Types of Contraceptives in Saudi Arabia: A Questionnaire-Based Study. Behavioral Sciences. 2024; 14(9):829. https://doi.org/10.3390/bs14090829
Chicago/Turabian StyleAlhakeem, Malak M., Leena R. Baghdadi, Almaha H. Alshathri, Aljohara H. Alshathri, Arwa A. Alqahtani, and Monerah H. Alshathri. 2024. "Risk Factors for Low Quality of Life among Women Using Different Types of Contraceptives in Saudi Arabia: A Questionnaire-Based Study" Behavioral Sciences 14, no. 9: 829. https://doi.org/10.3390/bs14090829
APA StyleAlhakeem, M. M., Baghdadi, L. R., Alshathri, A. H., Alshathri, A. H., Alqahtani, A. A., & Alshathri, M. H. (2024). Risk Factors for Low Quality of Life among Women Using Different Types of Contraceptives in Saudi Arabia: A Questionnaire-Based Study. Behavioral Sciences, 14(9), 829. https://doi.org/10.3390/bs14090829